Current evidence on the use of anakinra in COVID-19

Despite the progressing knowledge in COVID-19 management, remdesivir is the only agent that got approval to inhibit viral replication. However, there are limited data about effective immunomodulatory agents to prevent cytokine release in COVID-19. Cytokine release syndrome in COVID-19 resembles seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Khani, Elnaz, Shahrabi, Marzieh, Rezaei, Haleh, Pourkarim, Fariba, Afsharirad, Hoda, Solduzian, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296834/
https://www.ncbi.nlm.nih.gov/pubmed/35905562
http://dx.doi.org/10.1016/j.intimp.2022.109075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296834/
https://www.ncbi.nlm.nih.gov/pubmed/35905562
http://dx.doi.org/10.1016/j.intimp.2022.109075

Ejemplares similares